
    
      This is a multi-center, prospective, open label, non-randomized study to collect safety and
      effectiveness data in subjects with central sleep apnea implanted with the remedÄ“ System. At
      least 500 subjects will be successfully implanted at approximately 50 sites in the United
      States and Europe.
    
  